PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Bark extracts containing betulin (MIC 12.5 µg/mL) showed anti-mycobacterial activity in vitro [PMID:25725435]
Total and butanol extracts were investigated for iron chelating, antioxidant, anti-inflammatory, and antiapoptotic activities in male albino rats [PMID:37169909]
Alnus incana is included in the recommended standard prick test panel for inhalants in Europe to confirm IgE-mediated allergic disease [PMID:23369181]
Evidence summary
PubMed sources
- 1.PMID: 23369181 (2013) — The skin prick test - European standards. · Clinical and translational allergy
- 2.PMID: 25725435 (2015) — Anti-mycobacterial triterpenes from the Canadian medicinal plant Alnus incana. · Journal of ethnopharmacology
- 3.PMID: 33863124 (1995) — Nitrogen fixation by Alnus incana and nitrogen transfer from A. incana to Pinus sylvestris influenced by macronutrients and ectomycorrhiza. · The New phytologist
- 4.PMID: 37169909 (2023) — The effect of Alnus incana (L.) Moench extracts in ameliorating iron overload-induced hepatotoxicity in male albino rats. · Scientific reports
- 5.PMID: 41120347 (2025) — Evaluation of cytokinin types and LED light spectra for enhanced production of diarylheptanoids in Alnus incana subsp. incana.